PMC:7242012 / 115-14501
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 55-84 | Gene | denotes | angiotensin‐converting enzyme | Gene:1636 |
| 7 | 143-167 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
| 9 | 313-339 | Disease | denotes | acute respiratory syndrome | MESH:D012120 |
| 32 | 608-625 | Species | denotes | novel coronavirus | Tax:2697049 |
| 33 | 627-636 | Species | denotes | 2019‐nCoV | Tax:2697049 |
| 34 | 707-716 | Species | denotes | 2019‐nCoV | Tax:2697049 |
| 35 | 722-735 | Species | denotes | coronaviruses | Tax:11118 |
| 36 | 865-888 | Species | denotes | human coronavirus, SARS | Tax:694009 |
| 37 | 889-892 | Species | denotes | CoV | Tax:11118 |
| 38 | 985-995 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 39 | 1103-1113 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 40 | 1183-1193 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 41 | 1657-1667 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 42 | 1718-1726 | Species | denotes | patients | Tax:9606 |
| 43 | 452-461 | Disease | denotes | pneumonia | MESH:D011014 |
| 44 | 463-482 | Disease | denotes | respiratory failure | MESH:D012131 |
| 45 | 488-493 | Disease | denotes | death | MESH:D003643 |
| 46 | 914-940 | Disease | denotes | acute respiratory syndrome | MESH:D012120 |
| 47 | 1138-1162 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
| 48 | 1164-1172 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 49 | 1564-1572 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 50 | 1732-1740 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 51 | 1781-1801 | Disease | denotes | SARS‐CoV‐2 infection | MESH:C000657245 |
| 52 | 1843-1851 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 53 | 1891-1899 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 55 | 1935-1943 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 67 | 2334-2341 | Species | denotes | persons | Tax:9606 |
| 68 | 2032-2040 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 69 | 2056-2062 | Disease | denotes | deaths | MESH:D003643 |
| 70 | 2184-2192 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 71 | 2203-2209 | Disease | denotes | deaths | MESH:D003643 |
| 72 | 2346-2354 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 73 | 2399-2407 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 74 | 2452-2460 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 75 | 2541-2547 | Disease | denotes | deaths | MESH:D003643 |
| 76 | 2645-2651 | Disease | denotes | deaths | MESH:D003643 |
| 77 | 2699-2707 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 87 | 2772-2782 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 88 | 2990-3000 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 89 | 3068-3078 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 90 | 3206-3213 | Species | denotes | persons | Tax:9606 |
| 91 | 3412-3422 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 92 | 2860-2868 | Disease | denotes | infected | MESH:D007239 |
| 93 | 3153-3161 | Disease | denotes | infected | MESH:D007239 |
| 94 | 3224-3232 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 95 | 3506-3526 | Disease | denotes | SARS‐CoV‐2 infection | MESH:C000657245 |
| 106 | 3611-3642 | Gene | denotes | angiotensin‐converting enzyme 2 | Gene:59272 |
| 107 | 3644-3648 | Gene | denotes | ACE2 | Gene:59272 |
| 108 | 3746-3750 | Gene | denotes | ACE2 | Gene:59272 |
| 109 | 3967-3980 | Gene | denotes | interleukin‐6 | Gene:3569 |
| 110 | 3982-3986 | Gene | denotes | IL‐6 | Gene:3569 |
| 111 | 3581-3589 | Species | denotes | SARS‐CoV | Tax:694009 |
| 112 | 3591-3601 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 113 | 3842-3852 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 114 | 3820-3828 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 115 | 3885-3890 | Disease | denotes | death | MESH:D003643 |
| 128 | 4571-4579 | Species | denotes | patients | Tax:9606 |
| 129 | 4090-4099 | Disease | denotes | infection | MESH:D007239 |
| 130 | 4112-4120 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 131 | 4214-4222 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 132 | 4227-4232 | Disease | denotes | fever | MESH:D005334 |
| 133 | 4251-4256 | Disease | denotes | cough | MESH:D003371 |
| 134 | 4354-4361 | Disease | denotes | anosmia | MESH:D000857 |
| 135 | 4366-4373 | Disease | denotes | ageusia | MESH:D000370 |
| 136 | 4407-4415 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 137 | 4494-4505 | Disease | denotes | lymphopenia | MESH:D008231 |
| 138 | 4585-4593 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 139 | 4690-4705 | Disease | denotes | viral pneumonia | |
| 153 | 5145-5163 | Gene | denotes | C‐reactive protein | Gene:1401 |
| 154 | 4862-4870 | Species | denotes | patients | Tax:9606 |
| 155 | 4895-4900 | Disease | denotes | Fever | MESH:D005334 |
| 156 | 4911-4916 | Disease | denotes | Cough | MESH:D003371 |
| 157 | 4951-4962 | Disease | denotes | Dyspnea 19 | MESH:C000657245 |
| 158 | 4969-4976 | Disease | denotes | Fatigue | MESH:D005221 |
| 159 | 4977-4984 | Disease | denotes | Myalgia | MESH:D063806 |
| 160 | 4995-5003 | Disease | denotes | Headache | MESH:D006261 |
| 161 | 5014-5020 | Disease | denotes | Nausea | MESH:D009325 |
| 162 | 5039-5047 | Disease | denotes | Diarrhea | MESH:D003967 |
| 163 | 5113-5124 | Disease | denotes | Lymphopenia | MESH:D008231 |
| 164 | 5320-5355 | Disease | denotes | Acute respiratory distress syndrome | MESH:D012128 |
| 165 | 5365-5374 | Disease | denotes | Mortality | MESH:D003643 |
| 167 | 4737-4745 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 172 | 6131-6141 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 173 | 5866-5874 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 174 | 6046-6054 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 175 | 6417-6425 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 181 | 6437-6445 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 182 | 6494-6502 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 183 | 6549-6558 | Disease | denotes | pneumonia | MESH:D011014 |
| 184 | 6575-6582 | Disease | denotes | dyspnea | MESH:D004417 |
| 185 | 6612-6629 | Disease | denotes | pulmonary disease | MESH:D008171 |
| 207 | 6794-6797 | Species | denotes | men | Tax:9606 |
| 208 | 6817-6825 | Species | denotes | patients | Tax:9606 |
| 209 | 6926-6932 | Species | denotes | people | Tax:9606 |
| 210 | 6985-6992 | Species | denotes | persons | Tax:9606 |
| 211 | 7065-7073 | Species | denotes | patients | Tax:9606 |
| 212 | 6762-6770 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 213 | 6892-6900 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 214 | 6909-6915 | Disease | denotes | deaths | MESH:D003643 |
| 215 | 6963-6969 | Disease | denotes | Deaths | MESH:D003643 |
| 216 | 7079-7087 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 217 | 7124-7131 | Disease | denotes | obesity | MESH:D009765 |
| 218 | 7133-7145 | Disease | denotes | hypertension | MESH:D006973 |
| 219 | 7147-7155 | Disease | denotes | diabetes | MESH:D003920 |
| 220 | 7161-7183 | Disease | denotes | cardiovascular disease | MESH:D002318 |
| 221 | 7278-7286 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 222 | 7296-7309 | Disease | denotes | liver disease | MESH:D008107 |
| 223 | 7321-7330 | Disease | denotes | cirrhosis | MESH:D005355 |
| 224 | 7554-7562 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 225 | 7646-7651 | Disease | denotes | COVID | MESH:C000657245 |
| 226 | 7652-7661 | Disease | denotes | mortality | MESH:D003643 |
| 227 | 7698-7706 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 235 | 8054-8062 | Species | denotes | Patients | Tax:9606 |
| 236 | 8144-8156 | Disease | denotes | Hypertension | MESH:D006973 |
| 237 | 8165-8182 | Disease | denotes | Diabetes mellitus | MESH:D003920 |
| 238 | 8202-8224 | Disease | denotes | Cardiovascular disease | MESH:D002318 |
| 239 | 8244-8265 | Disease | denotes | Chronic renal disease | MESH:D051436 |
| 240 | 8293-8306 | Disease | denotes | liver disease | MESH:D008107 |
| 241 | 8357-8366 | Disease | denotes | Mortality | MESH:D003643 |
| 244 | 7907-7914 | Species | denotes | Persons | Tax:9606 |
| 245 | 7920-7928 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 253 | 9278-9282 | Gene | denotes | IL‐6 | Gene:3569 |
| 254 | 9145-9155 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 255 | 9424-9442 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 256 | 9446-9457 | Chemical | denotes | chloroquine | MESH:D002738 |
| 257 | 9227-9235 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 258 | 9360-9378 | Disease | denotes | cardiac arrythmias | MESH:D001145 |
| 259 | 9475-9483 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 266 | 9784-9792 | Species | denotes | patients | Tax:9606 |
| 267 | 10732-10742 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 268 | 9798-9806 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 269 | 10343-10351 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 270 | 10567-10573 | Disease | denotes | deaths | MESH:D003643 |
| 271 | 10628-10636 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 296 | 11539-11546 | Species | denotes | persons | Tax:9606 |
| 297 | 11626-11633 | Species | denotes | Persons | Tax:9606 |
| 298 | 12003-12011 | Species | denotes | patients | Tax:9606 |
| 299 | 12159-12167 | Species | denotes | patients | Tax:9606 |
| 300 | 12342-12350 | Species | denotes | patients | Tax:9606 |
| 301 | 12351-12358 | Species | denotes | Persons | Tax:9606 |
| 302 | 12835-12856 | Species | denotes | coronavirus/2019-ncov | Tax:2697049 |
| 303 | 11038-11043 | Chemical | denotes | water | MESH:D014867 |
| 304 | 11244-11249 | Chemical | denotes | water | MESH:D014867 |
| 305 | 11387-11392 | Chemical | denotes | water | MESH:D014867 |
| 306 | 10957-10965 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 307 | 11140-11145 | Disease | denotes | cough | MESH:D003371 |
| 308 | 11451-11459 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 309 | 11615-11620 | Disease | denotes | COVID | MESH:C000657245 |
| 310 | 12072-12080 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 311 | 12237-12246 | Disease | denotes | infection | MESH:D007239 |
| 312 | 12376-12384 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 313 | 12717-12725 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 314 | 12942-12977 | Disease | denotes | coronavirus-2019 Infectious Disease | MESH:C000657245 |
| 315 | 13038-13046 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 316 | 13102-13116 | Disease | denotes | Liver Diseases | MESH:D008107 |
| 317 | 13152-13160 | Disease | denotes | covid-19 | MESH:C000657245 |
| 318 | 13236-13244 | Disease | denotes | covid-19 | MESH:C000657245 |
| 319 | 13342-13350 | Disease | denotes | covid-19 | MESH:C000657245 |
| 321 | 10847-10855 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 332 | 13781-13791 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 333 | 13801-13806 | Species | denotes | human | Tax:9606 |
| 334 | 13905-13908 | Species | denotes | Men | Tax:9606 |
| 335 | 13944-13951 | Species | denotes | persons | Tax:9606 |
| 336 | 14181-14188 | Species | denotes | persons | Tax:9606 |
| 337 | 13886-13894 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 338 | 13994-14002 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 339 | 14007-14012 | Disease | denotes | death | MESH:D003643 |
| 340 | 14164-14172 | Disease | denotes | infected | MESH:D007239 |
| 341 | 14225-14233 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 232-245 | Body_part | denotes | interleukin‐6 | http://purl.org/sig/ont/fma/fma264829 |
| T2 | 232-243 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
| T3 | 2931-2935 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
| T4 | 3691-3716 | Body_part | denotes | alveolar epithelial cells | http://purl.org/sig/ont/fma/fma62499 |
| T5 | 3711-3716 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T6 | 3735-3740 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T7 | 3768-3773 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
| T8 | 3775-3797 | Body_part | denotes | gastrointestinal tract | http://purl.org/sig/ont/fma/fma71132 |
| T9 | 3803-3810 | Body_part | denotes | kidneys | http://purl.org/sig/ont/fma/fma7203 |
| T10 | 3880-3884 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T11 | 3950-3959 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
| T12 | 3967-3980 | Body_part | denotes | interleukin‐6 | http://purl.org/sig/ont/fma/fma264829 |
| T13 | 3967-3978 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
| T14 | 4000-4008 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
| T15 | 4477-4486 | Body_part | denotes | leukocyte | http://purl.org/sig/ont/fma/fma62852 |
| T16 | 4531-4538 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T17 | 4638-4643 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T18 | 5076-5086 | Body_part | denotes | Leukocytes | http://purl.org/sig/ont/fma/fma62852 |
| T19 | 5156-5163 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T20 | 5174-5181 | Body_part | denotes | Alanine | http://purl.org/sig/ont/fma/fma82749 |
| T21 | 5254-5259 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T22 | 5952-5960 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
| T23 | 5997-6003 | Body_part | denotes | sputum | http://purl.org/sig/ont/fma/fma312401 |
| T24 | 6142-6145 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T25 | 6150-6153 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T26 | 6402-6406 | Body_part | denotes | sole | http://purl.org/sig/ont/fma/fma25000 |
| T27 | 7296-7301 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
| T28 | 8293-8298 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
| T29 | 9184-9194 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
| T30 | 9299-9313 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T31 | 11086-11090 | Body_part | denotes | eyes | http://purl.org/sig/ont/fma/fma54448 |
| T32 | 11092-11096 | Body_part | denotes | nose | http://purl.org/sig/ont/fma/fma46472 |
| T33 | 11102-11107 | Body_part | denotes | mouth | http://purl.org/sig/ont/fma/fma49184 |
| T34 | 11153-11159 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
| T35 | 11177-11182 | Body_part | denotes | elbow | http://purl.org/sig/ont/fma/fma24901 |
| T36 | 11822-11826 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
| T37 | 13102-13107 | Body_part | denotes | Liver | http://purl.org/sig/ont/fma/fma7197 |
| T38 | 13213-13218 | Body_part | denotes | Liver | http://purl.org/sig/ont/fma/fma7197 |
| T39 | 13253-13258 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 2931-2935 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
| T2 | 3768-3773 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
| T3 | 4000-4014 | Body_part | denotes | alveolar walls | http://purl.obolibrary.org/obo/UBERON_0004894 |
| T4 | 4638-4643 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T5 | 5254-5259 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T6 | 5997-6003 | Body_part | denotes | sputum | http://purl.obolibrary.org/obo/UBERON_0007311 |
| T7 | 7296-7301 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T8 | 8293-8298 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T9 | 10374-10379 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
| T10 | 10996-11001 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T11 | 11092-11096 | Body_part | denotes | nose | http://purl.obolibrary.org/obo/UBERON_0000004 |
| T12 | 11102-11107 | Body_part | denotes | mouth | http://purl.obolibrary.org/obo/UBERON_0000165 |
| T13 | 11122-11127 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T14 | 11153-11159 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T15 | 11177-11182 | Body_part | denotes | elbow | http://purl.obolibrary.org/obo/UBERON_0001461 |
| T16 | 11800-11804 | Body_part | denotes | feet | http://purl.obolibrary.org/obo/UBERON_0002387 |
| T17 | 11822-11826 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
| T18 | 13102-13107 | Body_part | denotes | Liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T19 | 13213-13218 | Body_part | denotes | Liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T20 | 13253-13258 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T21 | 14282-14287 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 134-142 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 143-167 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 301-305 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T6 | 306-339 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T7 | 452-461 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T8 | 463-482 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
| T9 | 884-888 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T10 | 907-940 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T11 | 942-946 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T12 | 985-989 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T13 | 1103-1107 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T14 | 1138-1162 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 1164-1172 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 1183-1187 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T17 | 1564-1572 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T18 | 1657-1661 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T19 | 1732-1740 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T20 | 1781-1785 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T21 | 1792-1801 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T22 | 1843-1851 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T23 | 1891-1899 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T24 | 1935-1943 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T25 | 2032-2040 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T26 | 2184-2192 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T27 | 2346-2354 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T28 | 2399-2407 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T29 | 2452-2460 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T30 | 2699-2707 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T31 | 2772-2776 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T32 | 2990-2994 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T33 | 3068-3072 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T34 | 3089-3099 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T35 | 3224-3232 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T36 | 3412-3416 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T37 | 3506-3510 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T38 | 3517-3526 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T39 | 3581-3585 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T40 | 3591-3595 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T41 | 3820-3828 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T42 | 3842-3846 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T43 | 4090-4099 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T44 | 4112-4120 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T45 | 4214-4222 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T46 | 4354-4361 | Disease | denotes | anosmia | http://purl.obolibrary.org/obo/MONDO_0010528 |
| T47 | 4407-4415 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T48 | 4494-4505 | Disease | denotes | lymphopenia | http://purl.obolibrary.org/obo/MONDO_0003783 |
| T49 | 4585-4593 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T50 | 4690-4705 | Disease | denotes | viral pneumonia | http://purl.obolibrary.org/obo/MONDO_0006012 |
| T51 | 4696-4705 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T52 | 4737-4745 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T53 | 5039-5047 | Disease | denotes | Diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
| T54 | 5113-5124 | Disease | denotes | Lymphopenia | http://purl.obolibrary.org/obo/MONDO_0003783 |
| T55 | 5320-5355 | Disease | denotes | Acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T56 | 5326-5355 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
| T57 | 5569-5577 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T58 | 5866-5874 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T59 | 6046-6054 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T60 | 6131-6135 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T61 | 6417-6425 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T62 | 6437-6445 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T63 | 6494-6502 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T64 | 6549-6558 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T65 | 6612-6629 | Disease | denotes | pulmonary disease | http://purl.obolibrary.org/obo/MONDO_0005275 |
| T66 | 6652-6656 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T67 | 6762-6770 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T68 | 6892-6900 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T69 | 7079-7087 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T70 | 7124-7131 | Disease | denotes | obesity | http://purl.obolibrary.org/obo/MONDO_0011122 |
| T71 | 7133-7145 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T72 | 7147-7155 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
| T73 | 7161-7183 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
| T74 | 7278-7286 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T75 | 7296-7309 | Disease | denotes | liver disease | http://purl.obolibrary.org/obo/MONDO_0005154 |
| T76 | 7321-7330 | Disease | denotes | cirrhosis | http://purl.obolibrary.org/obo/MONDO_0005155 |
| T77 | 7554-7562 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T78 | 7698-7706 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T79 | 7920-7928 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T80 | 8128-8135 | Disease | denotes | Obesity | http://purl.obolibrary.org/obo/MONDO_0011122 |
| T81 | 8144-8156 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T82 | 8165-8182 | Disease | denotes | Diabetes mellitus | http://purl.obolibrary.org/obo/MONDO_0005015 |
| T83 | 8202-8224 | Disease | denotes | Cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
| T84 | 8244-8265 | Disease | denotes | Chronic renal disease | http://purl.obolibrary.org/obo/MONDO_0024327 |
| T85 | 8252-8265 | Disease | denotes | renal disease | http://purl.obolibrary.org/obo/MONDO_0002118|http://purl.obolibrary.org/obo/MONDO_0005240 |
| T87 | 8293-8306 | Disease | denotes | liver disease | http://purl.obolibrary.org/obo/MONDO_0005154 |
| T88 | 8622-8630 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T89 | 9227-9235 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T90 | 9475-9483 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T91 | 9798-9806 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T92 | 10343-10351 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T93 | 10628-10636 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T94 | 10732-10736 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T95 | 10847-10855 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T96 | 10957-10965 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T97 | 11451-11459 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T98 | 11615-11623 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T99 | 12072-12080 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T100 | 12237-12246 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T101 | 12376-12384 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T102 | 12717-12725 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T103 | 12959-12969 | Disease | denotes | Infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T104 | 13038-13046 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T105 | 13546-13554 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T106 | 13781-13785 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T107 | 13886-13894 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T108 | 13994-14002 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T109 | 14225-14233 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 87-90 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T3 | 232-245 | http://purl.obolibrary.org/obo/PR_000001393 | denotes | interleukin‐6 |
| T4 | 357-369 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T5 | 429-431 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T6 | 518-519 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T7 | 525-531 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T8 | 606-607 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 739-743 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bats |
| T10 | 802-808 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T11 | 865-870 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T12 | 949-955 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 3 , 4 |
| T13 | 1002-1008 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T14 | 1056-1068 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T15 | 1097-1102 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T16 | 1344-1345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T17 | 1346-1348 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T18 | 1478-1479 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T19 | 1539-1541 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T20 | 1573-1574 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T21 | 1977-1979 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T22 | 2418-2424 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T23 | 2470-2473 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T24 | 2588-2591 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T25 | 2659-2665 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T26 | 2931-2935 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T27 | 2968-2975 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | objects |
| T28 | 3379-3385 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T29 | 3700-3710 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
| T30 | 3711-3716 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T31 | 3735-3740 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T32 | 3768-3773 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
| T33 | 3768-3773 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
| T34 | 3768-3773 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
| T35 | 3768-3773 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
| T36 | 3775-3797 | http://purl.obolibrary.org/obo/UBERON_0005409 | denotes | gastrointestinal tract |
| T37 | 3803-3810 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidneys |
| T38 | 3803-3810 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidneys |
| T39 | 3803-3810 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidneys |
| T40 | 3880-3884 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T41 | 3923-3924 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T42 | 3967-3980 | http://purl.obolibrary.org/obo/PR_000001393 | denotes | interleukin‐6 |
| T43 | 4161-4165 | http://purl.obolibrary.org/obo/CLO_0053001 | denotes | 1‐14 |
| T44 | 4178-4184 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T45 | 4334-4337 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T46 | 4468-4469 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T47 | 4599-4600 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T48 | 4638-4643 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T49 | 4942-4944 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T50 | 4965-4967 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T51 | 5104-5106 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
| T52 | 5254-5259 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T53 | 5886-5890 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T54 | 5892-5898 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T55 | 5934-5941 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T56 | 6086-6093 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T57 | 6095-6101 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 2 , 7 |
| T58 | 6115-6120 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T59 | 6200-6204 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T60 | 6336-6341 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T61 | 6458-6459 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T62 | 6688-6689 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T63 | 6959-6961 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T64 | 7021-7023 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T65 | 7189-7191 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T66 | 7227-7230 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T67 | 7234-7235 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T68 | 7296-7301 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T69 | 7296-7301 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
| T70 | 7332-7335 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T71 | 7345-7346 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T72 | 8109-8111 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T73 | 8114-8116 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
| T74 | 8198-8200 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T75 | 8240-8242 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
| T76 | 8293-8298 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T77 | 8293-8298 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
| T78 | 8308-8313 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 1% 1 |
| T79 | 8342-8347 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 3% 6 |
| T80 | 8437-8440 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T81 | 8514-8516 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T82 | 8887-8888 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T83 | 8913-8914 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T84 | 9157-9158 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T85 | 9485-9486 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T86 | 9583-9585 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
| T87 | 9624-9625 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T88 | 9661-9662 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T89 | 9971-9978 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T90 | 10386-10393 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T91 | 10472-10479 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T92 | 10651-10658 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T93 | 10882-10889 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Testing |
| T94 | 11086-11090 | http://www.ebi.ac.uk/efo/EFO_0000827 | denotes | eyes |
| T95 | 11092-11096 | http://www.ebi.ac.uk/efo/EFO_0000828 | denotes | nose |
| T96 | 11102-11107 | http://www.ebi.ac.uk/efo/EFO_0000825 | denotes | mouth |
| T97 | 11151-11152 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T98 | 11647-11653 | http://purl.obolibrary.org/obo/PR_000001898 | denotes | call a |
| T99 | 11814-11815 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T100 | 11822-11826 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T101 | 12278-12285 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T102 | 12881-12893 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T103 | 13102-13107 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | Liver |
| T104 | 13102-13107 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | Liver |
| T105 | 13213-13218 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | Liver |
| T106 | 13213-13218 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | Liver |
| T107 | 13253-13258 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T108 | 13253-13258 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
| T109 | 13339-13341 | http://purl.obolibrary.org/obo/CLO_0037161 | denotes | en |
| T110 | 13795-13796 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T111 | 13801-13806 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T112 | 14141-14148 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 55-66 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T2 | 227-229 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T4 | 3611-3622 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T5 | 3982-3984 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T7 | 4531-4538 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T8 | 5156-5163 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T9 | 5174-5181 | Chemical | denotes | Alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
| T10 | 9145-9155 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T11 | 9174-9183 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T12 | 9184-9194 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
| T13 | 9195-9202 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
| T14 | 9278-9280 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T16 | 9424-9442 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T17 | 9446-9457 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T18 | 11038-11043 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
| T19 | 11051-11058 | Chemical | denotes | alcohol | http://purl.obolibrary.org/obo/CHEBI_16236|http://purl.obolibrary.org/obo/CHEBI_30879 |
| T21 | 11244-11249 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
| T22 | 11307-11320 | Chemical | denotes | disinfectants | http://purl.obolibrary.org/obo/CHEBI_48219 |
| T23 | 11331-11339 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
| T24 | 11387-11392 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
| T25 | 13339-13341 | Chemical | denotes | en | http://purl.obolibrary.org/obo/CHEBI_30347 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 253-274 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | reverse transcription |
| T2 | 261-274 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
| T3 | 3674-3685 | http://purl.obolibrary.org/obo/GO_0006897 | denotes | endocytosis |
| T4 | 3880-3890 | http://purl.obolibrary.org/obo/GO_0008219 | denotes | cell death |
| T5 | 3898-3907 | http://purl.obolibrary.org/obo/GO_0097194 | denotes | apoptosis |
| T6 | 3898-3907 | http://purl.obolibrary.org/obo/GO_0006915 | denotes | apoptosis |
| T7 | 4397-4402 | http://purl.obolibrary.org/obo/GO_0050909 | denotes | taste |
| T8 | 5802-5823 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | reverse transcription |
| T9 | 5810-5823 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-35 | Sentence | denotes | Watch the interview with the author |
| T6 | 36-49 | Sentence | denotes | Abbreviations |
| T7 | 50-86 | Sentence | denotes | ACE2 angiotensin‐converting enzyme 2 |
| T8 | 87-133 | Sentence | denotes | CDC Centers for Disease Control and Prevention |
| T9 | 134-167 | Sentence | denotes | COVID‐19 coronavirus disease 2019 |
| T10 | 168-190 | Sentence | denotes | CT computed tomography |
| T11 | 191-226 | Sentence | denotes | FDA US Food and Drug Administration |
| T12 | 227-245 | Sentence | denotes | IL‐6 interleukin‐6 |
| T13 | 246-300 | Sentence | denotes | RT‐PCR reverse transcription polymerase chain reaction |
| T14 | 301-339 | Sentence | denotes | SARS severe acute respiratory syndrome |
| T15 | 340-369 | Sentence | denotes | WHO World Health Organization |
| T16 | 370-548 | Sentence | denotes | On December 29, 2019, health authorities in China reported 27 cases of an unusual pneumonia, respiratory failure, and death linked to attendance at a live animal market in Wuhan. |
| T17 | 549-661 | Sentence | denotes | 1 , 2 On January 7, 2020, Chinese scientists confirmed a novel coronavirus, 2019‐nCoV, as the causative agent. |
| T18 | 662-948 | Sentence | denotes | 3 Studies revealed >80% genetic homology of 2019‐nCoV with coronaviruses of bats, presumably the original host; pangolins, suggesting this animal sold at the market as an intermediate host; and another human coronavirus, SARS‐CoV, the cause of severe acute respiratory syndrome (SARS). |
| T19 | 949-1035 | Sentence | denotes | 3 , 4 All evidence indicates that SARS‐CoV‐2 is of animal and not laboratory origin. |
| T20 | 1036-1174 | Sentence | denotes | 5 The World Health Organization (WHO) later named the novel virus SARS‐CoV‐2 and the related disease coronavirus disease 2019 (COVID‐19). |
| T21 | 1175-1267 | Sentence | denotes | 2 , 3 SARS‐CoV‐2 spread quickly through communities in China and other countries (Fig. 1). |
| T22 | 1268-1422 | Sentence | denotes | On January 20, 2020, the first case was recognized in the United State when a 35‐year‐old man presented to an urgent care clinic in Snohomish, Washington. |
| T23 | 1423-1529 | Sentence | denotes | 6 , 7 On January 30, 2020, WHO declared the outbreak a Public Health Emergency of International Concern. |
| T24 | 1530-1584 | Sentence | denotes | On March 11, 2020, WHO designated COVID‐19 a pandemic. |
| T25 | 1585-1741 | Sentence | denotes | Almost all countries are implementing public health measures to prevent SARS‐CoV‐2 transmission and are marshaling clinical care for patients with COVID‐19. |
| T26 | 1742-1909 | Sentence | denotes | This review highlights key features of SARS‐CoV‐2 infection, the epidemiology and clinical course of COVID‐19, and interventions to stop the growing COVID‐19 pandemic. |
| T27 | 1910-1953 | Sentence | denotes | Fig 1 Chronology of the COVID‐19 pandemic. |
| T28 | 1955-1967 | Sentence | denotes | Epidemiology |
| T29 | 1968-2063 | Sentence | denotes | By March 11, 2020, 105 countries had reported 118,319 confirmed COVID‐19 cases and 4292 deaths. |
| T30 | 2064-2138 | Sentence | denotes | 2 Outside China, large epidemics emerged in South Korea, Iran, and Italy. |
| T31 | 2139-2225 | Sentence | denotes | By March 14, 2020, approximately one in four COVID‐19 cases and deaths were in Europe. |
| T32 | 2226-2293 | Sentence | denotes | The US epidemic accelerated, with cases doubling every 6 to 7 days. |
| T33 | 2294-2417 | Sentence | denotes | 7 By March 29, 2020, more than 100,000 persons had COVID‐19 in the United States, the largest burden of COVID‐19 globally. |
| T34 | 2418-2565 | Sentence | denotes | 2 , 7 As of April 29, 2020, the COVID‐19 pandemic has grown to more than 3 million confirmed cases and more than 206,000 deaths in 179 countries. |
| T35 | 2566-2658 | Sentence | denotes | The United States now has more than 1 million cases (33%) and more than 50,000 deaths (25%). |
| T36 | 2659-2771 | Sentence | denotes | 2 , 7 The potential is high for large COVID‐19 epidemics in Brazil, Russia, India, and many African countries. |
| T37 | 2772-2976 | Sentence | denotes | SARS‐CoV‐2 is transmitted directly through inhalation or mucosal surface exposure to an infected person’s respiratory droplets or indirectly when touching the face after contact with contaminated objects. |
| T38 | 2977-3064 | Sentence | denotes | 2 , 4 , 7 SARS‐CoV‐2 can remain viable on environmental surfaces for up to 72 hours. |
| T39 | 3065-3214 | Sentence | denotes | 8 SARS‐CoV‐2 is highly infectious with an R0 of approximately 2.2 to 3.0, meaning each infected person will infect about two to three other persons. |
| T40 | 3215-3469 | Sentence | denotes | 7 Large COVID‐19 outbreaks have occurred in health care facilities, households, cruise ships, religious services (e.g., funerals), and other large gatherings 1 , 2 , 7 Individuals can transmit SARS‐CoV‐2 before, during, and after symptomatic disease. |
| T41 | 3470-3544 | Sentence | denotes | As many as half of individuals with SARS‐CoV‐2 infection have no symptoms. |
| T42 | 3545-3546 | Sentence | denotes | 7 |
| T43 | 3548-3569 | Sentence | denotes | Clinical Presentation |
| T44 | 3570-3811 | Sentence | denotes | Similar to SARS‐CoV, SARS‐CoV‐2 binds to angiotensin‐converting enzyme 2 (ACE2) receptors for entry via endocytosis into alveolar epithelial cells, as well as other cells with ACE2 receptors in the heart, gastrointestinal tract, and kidneys. |
| T45 | 3812-4060 | Sentence | denotes | 2 , 4 COVID‐19 results from SARS‐CoV‐2 replication, causing early cell death (i.e., apoptosis) and provoking a storm of proinflammatory cytokines (e.g., interleukin‐6 [IL‐6]) disrupting alveolar walls with resulting fluid accumulation in alveoli. |
| T46 | 4061-4062 | Sentence | denotes | 4 |
| T47 | 4063-4172 | Sentence | denotes | The incubation period from infection to onset of COVID‐19 disease is typically 5 to 7 days (range 1‐14 days). |
| T48 | 4173-4267 | Sentence | denotes | 1 , 2 , 7 The most common symptoms of COVID‐19 are fever and nonproductive cough (Table 1). |
| T49 | 4268-4425 | Sentence | denotes | 1 , 4 , 7 , 9 The Centers for Disease Control and Prevention (CDC) recently added anosmia and ageusia, the loss of smell and taste, as COVID‐19 symptoms. |
| T50 | 4426-4539 | Sentence | denotes | 7 Laboratory findings are remarkable for a normal leukocyte count, lymphopenia, and elevated C‐reactive protein. |
| T51 | 4540-4706 | Sentence | denotes | 1 , 6 , 8 Most hospitalized patients with COVID‐19 have a bilateral ground‐glass appearance on chest computed tomography (CT) scan consistent with viral pneumonia. |
| T52 | 4707-4792 | Sentence | denotes | Table 1 Clinical Features of COVID‐19 in Wuhan and Multiple Other Locations in China |
| T53 | 4793-4851 | Sentence | denotes | Clinical Features Wuhan, China Multiple Locations, China |
| T54 | 4852-4885 | Sentence | denotes | Number of patients 10,999 3,062 |
| T55 | 4886-4894 | Sentence | denotes | Symptoms |
| T56 | 4895-4910 | Sentence | denotes | Fever 89% 80% |
| T57 | 4911-4926 | Sentence | denotes | Cough 68% 63% |
| T58 | 4927-4950 | Sentence | denotes | Expectoration 34% 42% |
| T59 | 4951-4968 | Sentence | denotes | Dyspnea 19% 34% |
| T60 | 4969-4994 | Sentence | denotes | Fatigue/Myalgia 38% 46% |
| T61 | 4995-5013 | Sentence | denotes | Headache 14% 15% |
| T62 | 5014-5038 | Sentence | denotes | Nausea/Vomiting 5% 10% |
| T63 | 5039-5056 | Sentence | denotes | Diarrhea 4% 13% |
| T64 | 5057-5075 | Sentence | denotes | Laboratory results |
| T65 | 5076-5112 | Sentence | denotes | Leukocytes in normal range 94% 70% |
| T66 | 5113-5134 | Sentence | denotes | Lymphopenia 83% 57% |
| T67 | 5135-5173 | Sentence | denotes | Increased C‐reactive protein 61% 74% |
| T68 | 5174-5236 | Sentence | denotes | Alanine aminotransferase above upper limit of normal 21% 29% |
| T69 | 5237-5244 | Sentence | denotes | Imaging |
| T70 | 5245-5272 | Sentence | denotes | Abnormal chest CT 86% 89% |
| T71 | 5273-5319 | Sentence | denotes | Bilateral infiltrates (ground glass) 56% 76% |
| T72 | 5320-5364 | Sentence | denotes | Acute respiratory distress syndrome 6% 20% |
| T73 | 5365-5384 | Sentence | denotes | Mortality 1.4% 6% |
| T74 | 5385-5410 | Sentence | denotes | Data are from Guna et al. |
| T75 | 5411-5461 | Sentence | denotes | 1 and Centers for Disease Control and Prevention. |
| T76 | 5462-5463 | Sentence | denotes | 7 |
| T77 | 5464-5611 | Sentence | denotes | John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. |
| T78 | 5612-5794 | Sentence | denotes | It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| T79 | 5795-5891 | Sentence | denotes | Today, reverse transcription polymerase chain reaction (RT‐PCR) is the COVID‐19 diagnostic test. |
| T80 | 5892-6041 | Sentence | denotes | 2 , 7 RT‐PCR sensitivity is highest for testing bronchial alveolar lavage fluid (93%) and declines for sputum (72%) and nasal swab (63%) specimens. |
| T81 | 6042-6094 | Sentence | denotes | 10 COVID‐19 diagnosis might require repeat testing. |
| T82 | 6095-6179 | Sentence | denotes | 2 , 7 Serological tests to detect SARS‐CoV‐2 IgM and IgG antibodies are available. |
| T83 | 6180-6436 | Sentence | denotes | However, because of test sensitivity and other quality concerns, the US Food and Drug Administration (FDA; https://www.fda.gov) advises current serological tests are best used for surveillance and research, and not as the sole basis for COVID‐19 diagnosis. |
| T84 | 6437-6473 | Sentence | denotes | COVID‐19 is commonly a mild disease. |
| T85 | 6474-6657 | Sentence | denotes | Of the first 72,314 COVID‐19 disease reported in China, 81% had no or mild pneumonia, 21% had severe dyspnea and radiological evidence of pulmonary disease, and 5% progressed to SARS. |
| T86 | 6658-6741 | Sentence | denotes | 1 Individuals can be ill for a week or longer before experiencing severe symptoms. |
| T87 | 6742-6853 | Sentence | denotes | The risk for severe COVID‐19 disease is highest for men, older adults, and patients with certain comorbidities. |
| T88 | 6854-6948 | Sentence | denotes | In the United States, 80% of reported COVID‐19–related deaths are among people aged ≥65 years. |
| T89 | 6949-7010 | Sentence | denotes | 7 , 9 , 11 Deaths are rare among persons <24 years of age. |
| T90 | 7011-7203 | Sentence | denotes | 1 , 7 , 11 In the United States, most hospitalized patients with COVID‐19 have comorbid conditions, including obesity, hypertension, diabetes, and cardiovascular disease 7 , 11 (Table 2). |
| T91 | 7204-7429 | Sentence | denotes | Although listed by the CDC as a comorbid condition associated with severe COVID‐19, chronic liver disease, including cirrhosis, has not been a common comorbidity associated with hospitalization in the United States (Table 2). |
| T92 | 7430-7571 | Sentence | denotes | The high prevalence of comorbid conditions can explain, in part, African Americans’ increased risk for hospitalization with COVID‐19 disease. |
| T93 | 7572-7662 | Sentence | denotes | 5 Variable comorbidity prevalence contributes to differences in national COVID mortality. |
| T94 | 7663-7870 | Sentence | denotes | Globally, crude fatality rates for COVID‐19 range from 0.2% in Singapore, to 2.0% to 3.0% in South Korea and Germany, to 4.3% for the United States, and to 10% to 13% in Spain, Italy, and the United Kingdom. |
| T95 | 7871-7877 | Sentence | denotes | 2 , 5 |
| T96 | 7878-7951 | Sentence | denotes | Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States |
| T97 | 7952-7992 | Sentence | denotes | Condition United States* New York City |
| T98 | 7993-8053 | Sentence | denotes | Not Hospitalized Hospitalized Intensive Care Hospitalized |
| T99 | 8054-8085 | Sentence | denotes | Patients 5143 1037 457 5700 |
| T100 | 8086-8127 | Sentence | denotes | One or more condition 27% 71% 78% 88% |
| T101 | 8128-8143 | Sentence | denotes | Obesity 42% |
| T102 | 8144-8164 | Sentence | denotes | Hypertension 57% |
| T103 | 8165-8201 | Sentence | denotes | Diabetes mellitus 6% 24% 32% 34% |
| T104 | 8202-8243 | Sentence | denotes | Cardiovascular disease 5% 23% 29% 18% |
| T105 | 8244-8284 | Sentence | denotes | Chronic renal disease 1% 9% 12% 0.6% |
| T106 | 8285-8322 | Sentence | denotes | Chronic liver disease 1% 1% 2% 9% |
| T107 | 8323-8356 | Sentence | denotes | Immunocompromised 3% 6% 9% 2% |
| T108 | 8357-8374 | Sentence | denotes | Mortality 21% |
| T109 | 8375-8388 | Sentence | denotes | Total 21% |
| T110 | 8389-8410 | Sentence | denotes | 1 Comorbidity 88% |
| T111 | 8411-8475 | Sentence | denotes | * Based on data from the CDC for all 50 states and territories. |
| T112 | 8476-8513 | Sentence | denotes | Otherwise, data are Richardson et al. |
| T113 | 8514-8516 | Sentence | denotes | 11 |
| T114 | 8517-8664 | Sentence | denotes | John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. |
| T115 | 8665-8847 | Sentence | denotes | It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| T116 | 8848-9081 | Sentence | denotes | The search for effective therapies and a vaccine is occurring at a remarkable pace, with at least 29 studies of therapeutic agents and 5 studies of candidate vaccines registered on ClinicalTrials.org (https://www.clinicaltrials.gov). |
| T117 | 9082-9236 | Sentence | denotes | On May 1, 2020, the FDA granted Emergency Use Authorization of remdesivir, a broad‐spectrum antiviral nucleotide prodrug for treatment of severe COVID‐19. |
| T118 | 9237-9330 | Sentence | denotes | Studies of monoclonal antibodies against IL‐6 and hyperimmune immunoglobulin are in progress. |
| T119 | 9331-9484 | Sentence | denotes | Following reports of serious cardiac arrythmias, the FDA cautioned clinicians of prescribing hydroxychloroquine or chloroquine for treatment of COVID‐19. |
| T120 | 9485-9593 | Sentence | denotes | A safe and effective vaccine, if successfully developed, probably will not be available for 12 to 18 months. |
| T121 | 9595-9605 | Sentence | denotes | Prevention |
| T122 | 9606-9869 | Sentence | denotes | In the absence of a vaccine, prevention is composed of a combination of nonpharmacological interventions for suppression of transmission to R0 <1 and mitigation of the number of patients with COVID‐19 who require intensive care and mechanical respiratory support. |
| T123 | 9870-10103 | Sentence | denotes | 12 Interventions include improved personal hygiene promotions, symptomatic screening and laboratory testing for case detection, contact tracing, household quarantine of those with transmission risks, and social distancing (Table 3). |
| T124 | 10104-10285 | Sentence | denotes | The United States and most other countries have implemented extensive travel restrictions, workplace and school closures, and cancellation of sporting and other large public events. |
| T125 | 10286-10427 | Sentence | denotes | China, South Korea, and Taiwan successfully curbed large COVID‐19 epidemics with prompt scale‐up of testing, contact tracing, and quarantine. |
| T126 | 10428-10574 | Sentence | denotes | 2 , 4 , 7 In the United States, although testing rates are low, models suggest prevention measures are reducing transmission and future deaths. |
| T127 | 10575-10794 | Sentence | denotes | 13 The US government recently recommended increased COVID‐19 surveillance, testing, and contact tracing with modified social distancing measures to sustain SARS‐CoV‐2 prevention while opening up education and commerce. |
| T128 | 10795-10797 | Sentence | denotes | 14 |
| T129 | 10798-10916 | Sentence | denotes | Table 3 Prevention Measures to Reduce Risks for COVID‐19, Priority Populations for Testing, and Information Resources |
| T130 | 10917-10988 | Sentence | denotes | Prevention measures to reduce risks for COVID‐19 Practice good hygiene |
| T131 | 10989-11068 | Sentence | denotes | ○ Wash hands often for >20 seconds with soap and water or 60% alcohol sanitizer |
| T132 | 11069-11127 | Sentence | denotes | ○ Avoid touching eyes, nose, and mouth with unwashed hands |
| T133 | 11128-11182 | Sentence | denotes | ○ Sneeze or cough into a tissue or inside of the elbow |
| T134 | 11183-11393 | Sentence | denotes | ○ Disinfect surfaces and used items frequently with soap and water and Environmental Protection Agency–registered household disinfectants or bleach solution (4 teaspoons [20 mL] bleach per quart [or 1 L] water) |
| T135 | 11394-11420 | Sentence | denotes | Limit close social contact |
| T136 | 11421-11492 | Sentence | denotes | ○ Learn signs and symptoms of COVID‐19, and follow local disease trends |
| T137 | 11493-11623 | Sentence | denotes | ○ Stay home as much as possible, particularly persons who are ill, older (>65 years) adults, and those at risk for severe COVID‐19 |
| T138 | 11624-11674 | Sentence | denotes | ○ Persons who are ill, call a health care provider |
| T139 | 11675-11742 | Sentence | denotes | ○ Consider 2‐week supply of medications, food, and other essentials |
| T140 | 11743-11832 | Sentence | denotes | ○ When out in public, keep social distance of at least 6 feet and wear a cloth face cover |
| T141 | 11833-11866 | Sentence | denotes | ○ Avoid gatherings of >10 persons |
| T142 | 11867-11900 | Sentence | denotes | ○ Work or attend school from home |
| T143 | 11901-11927 | Sentence | denotes | ○ Avoid unnecessary travel |
| T144 | 11928-11994 | Sentence | denotes | ○ Avoid visits to nursing homes or long‐term retirement facilities |
| T145 | 11995-12035 | Sentence | denotes | Protect patients and health care workers |
| T146 | 12036-12136 | Sentence | denotes | ○ Reduce facility risks: screen for COVID‐19 symptoms on entry; reduce visits; practice telemedicine |
| T147 | 12137-12187 | Sentence | denotes | ○ Isolate symptomatic patients as soon as possible |
| T148 | 12188-12265 | Sentence | denotes | ○ Protect health care personnel with recommended infection‐control procedures |
| T149 | 12266-12350 | Sentence | denotes | Recommended testing in consultation with health care provider Hospitalized patients |
| T150 | 12351-12384 | Sentence | denotes | Persons with symptoms of COVID‐19 |
| T151 | 12385-12415 | Sentence | denotes | ○ Health care facility workers |
| T152 | 12416-12455 | Sentence | denotes | ○ Patients in long‐term care facilities |
| T153 | 12456-12483 | Sentence | denotes | ○ Patients >65 years of age |
| T154 | 12484-12535 | Sentence | denotes | ○ Patients with underlying conditions with symptoms |
| T155 | 12536-12554 | Sentence | denotes | ○ First responders |
| T156 | 12555-12611 | Sentence | denotes | Critical infrastructure workers and others with symptoms |
| T157 | 12612-12661 | Sentence | denotes | Health care facility workers and first responders |
| T158 | 12662-12742 | Sentence | denotes | Persons mildly ill in communities with high numbers of COVID‐19 hospitalizations |
| T159 | 12743-12867 | Sentence | denotes | Good information resources Centers for Disease Control and Prevention: https://www.cdc.gov/coronavirus/2019-ncov/index.html |
| T160 | 12868-12958 | Sentence | denotes | World Health Organization: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 |
| T161 | 12959-13063 | Sentence | denotes | Infectious Disease Society of America: https://www.idsociety.org/public-health/COVID-19-Resource-Center/ |
| T162 | 13064-13170 | Sentence | denotes | American Association for the Study of Liver Diseases: https://www.aasld.org/about-aasld/covid-19-resources |
| T163 | 13171-13259 | Sentence | denotes | European Association for the Study of the Liver: https://easl.eu/covid-19-and-the-liver/ |
| T164 | 13260-13359 | Sentence | denotes | European Centre for Disease Control and Prevention: https://www.ecdc.europa.eu/en/covid-19-pandemic |
| T165 | 13360-13440 | Sentence | denotes | The Society for Healthcare Epidemiology of America: https://www.shea-online.org/ |
| T166 | 13441-13588 | Sentence | denotes | John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. |
| T167 | 13589-13771 | Sentence | denotes | It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| T168 | 13773-13780 | Sentence | denotes | Summary |
| T169 | 13781-13904 | Sentence | denotes | SARS‐CoV‐2 is a new human pathogen, readily spread via respiratory droplets and the cause of the growing COVID‐19 pandemic. |
| T170 | 13905-14013 | Sentence | denotes | Men, older adults (>65 years old), and persons with comorbidities are at risk for severe COVID‐19 and death. |
| T171 | 14014-14212 | Sentence | denotes | Countries have successfully suppressed transmission and mitigated needs for intensive care with robust case/contact detection (testing), isolation of infected/exposed persons, and social distancing. |
| T172 | 14213-14386 | Sentence | denotes | To stop the COVID‐19 pandemic, the challenge is for all countries to scale up and sustain prevention measures while awaiting the arrival of effective vaccines and therapies. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 452-461 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
| T2 | 463-482 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
| T3 | 4227-4232 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T4 | 4237-4256 | Phenotype | denotes | nonproductive cough | http://purl.obolibrary.org/obo/HP_0031246 |
| T5 | 4354-4361 | Phenotype | denotes | anosmia | http://purl.obolibrary.org/obo/HP_0000458 |
| T6 | 4366-4373 | Phenotype | denotes | ageusia | http://purl.obolibrary.org/obo/HP_0041051 |
| T7 | 4379-4392 | Phenotype | denotes | loss of smell | http://purl.obolibrary.org/obo/HP_0000458 |
| T8 | 4494-4505 | Phenotype | denotes | lymphopenia | http://purl.obolibrary.org/obo/HP_0001888 |
| T9 | 4696-4705 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
| T10 | 4895-4900 | Phenotype | denotes | Fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T11 | 4911-4916 | Phenotype | denotes | Cough | http://purl.obolibrary.org/obo/HP_0012735 |
| T12 | 4951-4958 | Phenotype | denotes | Dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
| T13 | 4969-4976 | Phenotype | denotes | Fatigue | http://purl.obolibrary.org/obo/HP_0012378 |
| T14 | 4977-4984 | Phenotype | denotes | Myalgia | http://purl.obolibrary.org/obo/HP_0003326 |
| T15 | 4995-5003 | Phenotype | denotes | Headache | http://purl.obolibrary.org/obo/HP_0002315 |
| T16 | 5014-5029 | Phenotype | denotes | Nausea/Vomiting | http://purl.obolibrary.org/obo/HP_0002017 |
| T17 | 5039-5047 | Phenotype | denotes | Diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
| T18 | 5113-5124 | Phenotype | denotes | Lymphopenia | http://purl.obolibrary.org/obo/HP_0001888 |
| T19 | 5326-5346 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
| T20 | 6549-6558 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
| T21 | 6575-6582 | Phenotype | denotes | dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
| T22 | 7124-7131 | Phenotype | denotes | obesity | http://purl.obolibrary.org/obo/HP_0001513 |
| T23 | 7133-7145 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T24 | 7161-7183 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
| T25 | 7296-7309 | Phenotype | denotes | liver disease | http://purl.obolibrary.org/obo/HP_0001392 |
| T26 | 7321-7330 | Phenotype | denotes | cirrhosis | http://purl.obolibrary.org/obo/HP_0001394 |
| T27 | 8128-8135 | Phenotype | denotes | Obesity | http://purl.obolibrary.org/obo/HP_0001513 |
| T28 | 8144-8156 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T29 | 8165-8182 | Phenotype | denotes | Diabetes mellitus | http://purl.obolibrary.org/obo/HP_0000819 |
| T30 | 8202-8224 | Phenotype | denotes | Cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
| T31 | 8293-8306 | Phenotype | denotes | liver disease | http://purl.obolibrary.org/obo/HP_0001392 |
| T32 | 11130-11136 | Phenotype | denotes | Sneeze | http://purl.obolibrary.org/obo/HP_0025095 |
| T33 | 11140-11145 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
| T34 | 13102-13116 | Phenotype | denotes | Liver Diseases | http://purl.obolibrary.org/obo/HP_0001392 |